ALG3 and breast cancer: X. Sun et al. reported that inducing the mannosylation of TGF-β receptor II (TGFBR2) by ALG3 promoted radioresistance and cancer stemness in breast cancer, whereas tunicamycin and LY2109761 abrogated the stimulatory effect of ALG3 overexpression [18].